Comerica Securities’s Verastem VSTM Stock Holding History

Comerica Securities’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-72	Closed	-$346	–	1395
2022 Q4	$346	Buy	+72	New	+$353	﹤0.01%	1446

Other funds holding VSTM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Comerica Securities's VSTM Position: Q1 2023 in Review

Comerica Securities sold out of Verastem (VSTM) in Q1 2023, closing a stake of 72 shares — an estimated $346 sold.

Comerica Securities first reported a position in VSTM in Q4 2022 and held it in 1 quarter. The position peaked at $346 in Q4 2022. 80 funds tracked by Wall St. Rank hold VSTM as of Q1 2023.

Comerica Securities reported no remaining Verastem position as of Q1 2023 after selling out during the quarter.
Comerica Securities sold 72 Verastem shares in Q1 2023, an estimated $346.
Comerica Securities first reported a position in Verastem in Q4 2022 and held it in 1 quarter.
Comerica Securities's Verastem position peaked at $346 in Q4 2022.
80 funds tracked by Wall St. Rank held Verastem as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.